China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong · Delayed Price · Currency is HKD 4.670
+0.050 (1.08%)
May 29, 2026, 4:08 PM HKT
HKG:3320 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 29,339 | 27,957 | 35,810 | 32,229 | 39,705 | 22,303 | |
Market Cap Growth | -5.66% | -21.93% | 11.11% | -18.83% | 78.03% | -10.80% |
Enterprise Value | 152,755 | 152,391 | 134,493 | 125,637 | 127,867 | 104,251 |
Last Close Price | 4.67 | 4.45 | 5.55 | 4.76 | 5.74 | 3.11 |
PE Ratio | 6.52 | 6.22 | 10.10 | 7.59 | 10.03 | 5.92 |
Forward PE | 5.95 | 6.57 | 7.10 | 6.11 | 8.75 | 5.81 |
PS Ratio | 0.10 | 0.09 | 0.13 | 0.12 | 0.16 | 0.09 |
PB Ratio | 0.22 | 0.21 | 0.34 | 0.32 | 0.44 | 0.24 |
P/TBV Ratio | 1.40 | 1.33 | 1.78 | 1.63 | 2.09 | 1.20 |
P/FCF Ratio | 1.45 | 1.39 | 2.26 | 2.25 | 4.11 | 2.14 |
P/OCF Ratio | 1.29 | 1.23 | 1.92 | 1.88 | 3.25 | 1.74 |
PEG Ratio | 0.53 | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 |
EV/Sales Ratio | 0.51 | 0.51 | 0.49 | 0.47 | 0.52 | 0.44 |
EV/EBITDA Ratio | 8.08 | 8.61 | 8.64 | 8.40 | 9.68 | 8.73 |
EV/EBIT Ratio | 10.63 | 10.83 | 10.55 | 10.34 | 11.61 | 10.59 |
EV/FCF Ratio | 7.56 | 7.55 | 8.49 | 8.75 | 13.24 | 10.00 |
Debt / Equity Ratio | 0.62 | 0.62 | 0.70 | 0.67 | 0.70 | 0.72 |
Debt / EBITDA Ratio | 4.35 | 4.35 | 4.50 | 4.38 | 4.59 | 5.37 |
Debt / FCF Ratio | 4.01 | 4.01 | 4.63 | 4.77 | 6.61 | 6.52 |
Net Debt / Equity Ratio | 0.38 | 0.38 | 0.44 | 0.32 | 0.42 | 0.41 |
Net Debt / EBITDA Ratio | 2.82 | 2.82 | 2.96 | 2.21 | 2.88 | 3.22 |
Net Debt / FCF Ratio | 2.47 | 2.47 | 2.91 | 2.30 | 3.94 | 3.69 |
Asset Turnover | 0.99 | 0.99 | 1.02 | 1.06 | 1.00 | 1.03 |
Inventory Turnover | 5.60 | 5.60 | 6.30 | 7.07 | 6.99 | 7.42 |
Quick Ratio | 1.00 | 1.00 | 1.03 | 1.00 | 0.94 | 0.95 |
Current Ratio | 1.42 | 1.42 | 1.41 | 1.33 | 1.25 | 1.25 |
Return on Equity (ROE) | 8.96% | 8.96% | 8.80% | 8.96% | 8.09% | 7.60% |
Return on Assets (ROA) | 2.91% | 2.91% | 2.97% | 2.98% | 2.80% | 2.69% |
Return on Invested Capital (ROIC) | 6.38% | 6.82% | 6.97% | 7.32% | 6.96% | 6.12% |
Return on Capital Employed (ROCE) | 8.80% | 8.80% | 9.50% | 9.80% | 10.40% | 9.20% |
Earnings Yield | 15.33% | 16.10% | 9.96% | 13.18% | 9.97% | 16.90% |
FCF Yield | 68.82% | 72.23% | 44.25% | 44.53% | 24.32% | 46.76% |
Dividend Yield | 4.80% | 4.85% | 2.59% | 3.56% | 2.79% | 4.82% |
Payout Ratio | 11.02% | 19.26% | 44.44% | 22.83% | 23.23% | 20.00% |
Buyback Yield / Dilution | - | - | - | - | - | 0.01% |
Total Shareholder Return | 4.80% | 4.85% | 2.59% | 3.56% | 2.79% | 4.83% |